Science Daily

Long Term Antiretroviral Therapy Could Restore Normal CD4 Cell Counts In HIV Positive Patients

HIV positive patients who take combination antiretroviral therapy (cART) to combat HIV infection could see the numbers of CD4 cells in their immune system rise to concentrations found in HIV negative ...
clinicaladvisor.com

Initiating antiretroviral therapy in HIV patients with CD4 T-cell counts >500 cells/mcL

HIV virus Recommendations for initiation of antiretroviral therapy (ART) in asymptomatic adults with HIV are generally based on CD4 T-cell counts. The START trial included 4,685 adults (mean age, 36 ...
ascopubs.org

The effect of androgen deprivation therapy on CD4/CD8 T cells in HIV-negative patients receiving definitive 3D radiation treatment for their prostate carcinoma: Final report of ...

Effect of the epidermal growth factor receptor antibody panitumumab on triggering of ADCC No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2009 ASCO Annual ...
Nature

Despite early antiretroviral therapy effector memory and follicular helper CD4 T cells are major reservoirs in visceral lymphoid tissues of SIV-infected macaques

To date, the identification of cellular and anatomic reservoirs and their eradication remains a major challenge for an HIV cure. 1 Our understanding of the effect of current drug regimens on virus ...
Nature

Prognosis of HIV Patients Receiving Antiretroviral Therapy According to CD4 Counts: A Long-term Follow-up study in Yunnan, China

We aim to evaluate the overall survival and associated risk factors for HIV-infected Chinese patients on antiretroviral therapy (ART). 2517 patients receiving ART between 2006 and 2016 were ...
Business Wire

Legend Biotech Begins Phase 1 Clinical Trial in the US to Evaluate Investigational Anti-CD4 CAR-T Therapy for Relapsed or Refractory T-Cell Lymphoma

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell ...